JUL 8, 2026 · JOURNAL ARTICLE
Post-vaccination HPV prevalence, genotype distribution, and associated factors among vaccinated women in China: A cross-sectional study.
Human Vaccines & Immunotherapeutics
Cross-sectional study with 893 participants demonstrates reduced post-vaccination HPV prevalence and identifies expected risk factors, reinforcing established vaccination strategies.
Reported
Sample size893
Post-vaccination HPV prevalence8.51%
AOR age ≥40y2.92